Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection - Wikidata - awgldk - TriplyDB

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

http://www.wikidata.org/entity/Q35990859

about

Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.Fc functional antibodies in humans with severe H7N9 and seasonal influenza Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs.Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?Strategies to induce broadly protective antibody responses to viral glycoproteins.Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody.Pandemic 2009 H1N1 Influenza Venus reporter virus reveals broad diversity of MHC class II-positive antigen-bearing cells following infection in vivo.Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies.Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.Structural Basis for CD4+ T Cell Epitope Dominance in Arbo-Flavivirus Envelope Proteins: A Meta-Analysis.Divergent Requirement of Fc-Fcγ Receptor Interactions for In Vivo Protection against Influenza Viruses by Two Pan-H5 Hemagglutinin Antibodies.HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design.Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.Development of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards.Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection.Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model.Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus.Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.The influenza virus hemagglutinin head evolves faster than the stalk domain An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses The Vestigial Esterase Domain of Haemagglutinin of H5N1 Avian Influenza A Virus: Antigenicity and Contribution to Viral Pathogenesis

P2860

Q28066918-6CA04F3D-5BD4-42BF-B48F-D0451414A1D0 Q30392944-E0C2DA07-67E7-40FC-B4F8-60C5E3E7ABCF Q30395259-28A3EE84-4328-4F58-BD17-D4AED9914477 Q30571702-9A4E37A6-D66F-4214-8168-E159497B4CDF Q33877811-5301CBA4-5492-44C1-AB08-30791057ECA8 Q37323172-9EF0551A-18B7-45C6-931E-88226BA19DC1 Q38644429-9416CB10-FCA9-44F2-A5F1-361863BE041A Q38686514-8F27392B-678C-4D7F-8626-A6818914AB99 Q38804059-1E7B30AE-7F9B-4E79-9A1E-113CBBC296BD Q39170802-CC72B077-E74C-4926-8E6B-267AB70F0EBC Q40041335-230CB4CD-EEEF-4FAA-B64F-497BDA2FD885 Q40052241-F8359B2C-7D25-48E7-852A-DAF51B3BEE9A Q40057948-E1B8442B-4AD2-41A8-8E88-A5EE0CA20931 Q40097582-1074906C-FC60-4613-8355-69EA0B673D71 Q40160412-205F276B-3BCE-4D23-99B9-7DEE0A53EFE0 Q40279321-5B250634-B370-4145-B70D-77378371DBE8 Q40539528-4EFAEACE-332E-4AD7-A4A5-E4C6045B57E8 Q41919615-7FDB2437-7A20-4FE7-BCAA-25C73C7B3AD8 Q41919718-47DE3A8E-488B-48B4-BE59-9A983F085D44 Q41922709-F05F06E5-6F24-4D56-A434-31D22DBA8F44 Q41933379-CB00F329-A0DB-4E43-B479-7FB242D9183D Q45323759-6CB26CC3-D4D4-4573-B8D0-AB378F0BCEF7 Q45324518-A83F1BDB-F884-4F7F-8F20-E237C343B6CD Q47132462-7FBB7CE7-931C-45BC-8511-BD180B6B545B Q47549109-88986208-DED8-4613-8125-E7FEFCE17C74 Q47576940-D76A80EB-CFF5-4A05-9B70-3D7DD41367FA Q49465358-444B20DC-4984-43B5-B94C-B17923B1754F Q52721336-4B21D2DB-FD4F-490B-916B-5B5D4C222D0B Q55260817-7480B3A7-B067-4E21-8B29-F5B7E95A6AAC Q55306089-C1EE3FA4-CC9F-4FAA-A831-471C6050DB0A Q55501368-769AFD4E-F550-407F-9BFF-67AD8A39726A Q56889702-02155A45-C857-40DE-BE04-87CD50D50FC8 Q57026121-24DDBF7A-A982-4D38-B8A0-4F1CCA1D08A0 Q58115616-69A2A176-CCCD-4130-A863-312D5C5B3AE0 Q58706119-7A108F5C-646B-45FE-AEDA-82D1E2F1132A Q58788757-C42C7E50-50CF-46C0-9760-620DC5D3462A

P2860

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

http://www.wikidata.org/entity/Q35990859

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Broadly-Reactive Neutralizing ...... rgent Mechanisms of Protection

@ast

Broadly-Reactive Neutralizing ...... rgent Mechanisms of Protection

@en

type

label

Broadly-Reactive Neutralizing ...... rgent Mechanisms of Protection

@ast

Broadly-Reactive Neutralizing ...... rgent Mechanisms of Protection

@en

prefLabel

Broadly-Reactive Neutralizing ...... rgent Mechanisms of Protection

@ast

Broadly-Reactive Neutralizing ...... rgent Mechanisms of Protection

@en

P1433

Q35990859-D57AFEA6-0258-4460-8F89-507B9D70CD88

P1476

Q35990859-7B9640E3-C6F3-4A48-B17B-898175CCB9A0

P2093

Q35990859-0C81929D-8C3A-4C5B-8CE2-072F53102464

Q35990859-271CF098-A96F-4318-8AE2-C1E13E556848

Q35990859-6B9C11FA-076D-47D9-93F7-6DD653FD376F

Q35990859-8825D769-E04F-4583-AC09-66782E0AD432

Q35990859-B09919A6-CCB0-4E59-9707-AA2FA496AA57

P2860

Q35990859-06E02087-75D2-49B8-AD6C-CF3ADF17713B

Q35990859-087C53CF-ED2D-497D-8D0C-71E0F2F0514A

Q35990859-0F229852-0A7F-4B87-87DA-0F8CF8E54254

Q35990859-1360B437-E218-4E33-A309-A24EEC1B1707

Q35990859-15C94DAC-DCF4-4A59-9FC3-A5F388B77EBF

Q35990859-179F6B20-3830-4A2B-841B-652BCC00A3A4

Q35990859-2668DED3-AD2A-4F54-9043-1BA636996BE2

Q35990859-27A76966-8D5F-4BF7-AE8E-F2A0B4D65273

Q35990859-33B9FBD2-D260-4365-86B7-394A41851370

Q35990859-33E378BD-29A8-44E8-9AFA-385D022691C8

P304

Q35990859-01D534B0-2A00-4B12-A820-2ACE6496D153

P31

Q35990859-2ABA594C-2665-46FB-9E75-395C5E333D01

P356

Q35990859-9C3C7CB6-2E90-4405-B949-0C3F8A69F469

P433

Q35990859-8922005D-62E0-432D-96AE-F72685C5C60C

P478

Q35990859-779BE977-0DDE-465F-AF45-7CF82E6AAB07

P50

Q35990859-9BAF07F5-DB47-4C6E-A8E3-D47454AE1051

Q35990859-AD76481A-9DCB-439D-BF81-DE2545DDB947

P577

Q35990859-C03C599D-911B-4CBE-98E2-356A6284AF42

P698

Q35990859-1943BC0C-E5BA-4666-B766-34A148D670B1

P921

Q35990859-1C98A890-1294-4C48-A79C-D0F3F6D5AC3C

P932

Q35990859-9B96B845-3FB0-4403-BFB8-6BCD97A690BD

P356

JOURNAL.PPAT.1005578

P1433

P1476

Broadly-Reactive Neutralizing ...... rgent Mechanisms of Protection

@en

P2093

Ariana Hirsh

http://www.w3.org/2001/XMLSchema#string

Irina Margine

http://www.w3.org/2001/XMLSchema#string

Justin Bahl

http://www.w3.org/2001/XMLSchema#string

Paul E Leon

http://www.w3.org/2001/XMLSchema#string

Randy A Albrecht

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

Human illness from avian influenza H7N3, British Columbia

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

MUSCLE: multiple sequence alignment with high accuracy and high throughput

Preferential Recognition of Avian-Like Receptors in Human Influenza A H7N9 Viruses

Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses

Human infection with a novel avian-origin influenza A (H7N9) virus

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.

A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults.

S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses.

P304

e1005578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1005578

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Florian Krammer

P577

2016-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27081859

http://www.w3.org/2001/XMLSchema#string

P921

P932

4833315

http://www.w3.org/2001/XMLSchema#string